NERM
BEAT

New England Research & Management’s BioTelemetry, Inc. BEAT Stock Holding History

New England Research & Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,675
Closed -$476K – 167
2019
Q3 		$476K Buy
11,675
+275
+2% +$11.9K 0.34% 101
2019
Q2 		$549K Buy
+11,400
New +$599K 0.37% 97
2018
Q2 		– Sell
-16,299
Closed -$506K – 186
2018
Q1 		$506K Buy
+16,299
New +$536K 0.34% 102

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

New England Research & Management's BEAT Position: Q4 2019 in Review

New England Research & Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 11,675 shares — an estimated $476K sold.

New England Research & Management first reported a position in BEAT in Q1 2018 and held it in 3 quarters. The position peaked at $549K in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • New England Research & Management reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • New England Research & Management sold 11,675 BioTelemetry, Inc. shares in Q4 2019, an estimated $476K.
  • New England Research & Management first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 3 quarters.
  • New England Research & Management's BioTelemetry, Inc. position peaked at $549K in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on New England Research & Management's 13F filing for Q4 2019, filed 14 Jan 2020.